Renaissance Technologies’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Renaissance Technologies’s Portfolio OMGA Stock Details OMGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-17,820	Closed	-$13.3K	–	3959
2024 Q4	$13.3K	Sell	17,820 -456,780	-96%	-$455K	﹤0.01%	3506
2024 Q3	$579K	Buy	474,600 +346,200	+270%	+$551K	﹤0.01%	2716
2024 Q2	$266K	Buy	+128,400	New	+$303K	﹤0.01%	2957
2024 Q1	–	Sell	-20,400	Closed	-$61K	–	4164
2023 Q4	$61K	Buy	+20,400	New	+$41.3K	﹤0.01%	3417
2022 Q3	–	Sell	-95,663	Closed	-$364K	–	4491
2022 Q2	$364K	Buy	+95,663	New	+$356K	﹤0.01%	3343

Other funds holding OMGA

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Renaissance Technologies's OMGA Position: Q1 2025 in Review

Renaissance Technologies sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 17,820 shares — an estimated $13.3K sold.

Renaissance Technologies first reported a position in OMGA in Q2 2022 and held it in 5 quarters. The position peaked at $579K in Q3 2024. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

Renaissance Technologies reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
Renaissance Technologies sold 17,820 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $13.3K.
Renaissance Technologies first reported a position in Omega Therapeutics, Inc. Common Stock in Q2 2022 and held it in 5 quarters.
Renaissance Technologies's Omega Therapeutics, Inc. Common Stock position peaked at $579K in Q3 2024.
4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Renaissance Technologies's 13F filing for Q1 2025, filed 14 May 2025.